TREATMENT OF SYSTEMIC PSEUDOMONAS-AERUGINOSA INFECTIONS WITH CEFTAZIDIME - CAUSES OF THERAPEUTIC FAILURE

被引：8

作者：

BLASER, J ^{[1
]}

BAUERNFEIND, A ^{[1
]}

VOGT, M ^{[1
]}

LUTHY, R ^{[1
]}

机构：

[1] UNIV MUNICH,MAX VON PETTENKOFER INST HYG & MED MIKROBIOL,D-8000 MUNICH 2,FED REP GER

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 1983年 / 108卷 / 35期

关键词：

D O I：

10.1055/s-2008-1069742

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1312 / 1317

页数：6

共 23 条

[1]

BAUER AW, 1966, AM J CLIN PATHOL, V45, P493

[2]

BAUERNFEIND A, 1978, ZBL BAKT-INT J MED M, V240, P271

[3] AN EVALUATION OF THE ACTIVITY OF CEPHALOSPORINS AGAINST PSEUDOMONAS-AERUGINOSA [J].

BAUERNFEIND, A .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :111-117

[4]

BAUERNFEIND A, INFECTION

[5] COMPARATIVE INVITRO ACTIVITY OF CEFTAZIDIME (GR-20263) AND OTHER BETA-LACTAMASE STABLE CEPHALOSPORINS AGAINST PSEUDOMONAS - EFFECT OF INOCULUM SIZE AND DIVALENT-CATION SUPPLEMENTATION [J].

CHOW, AW ;

BARTLETT, KH .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :345-348

[6]

DEMARIA A, 1980, 20TH INT C ANT AG CH

[7]

Gavan T. L., 1980, MANUAL CLIN MICROBIO, P459

[8] CEFTAZIDIME, A PSEUDOMONAS-ACTIVE CEPHALOSPORIN - INVITRO ANTIMICROBIAL ACTIVITY EVALUATION INCLUDING RECOMMENDATIONS FOR DISK DIFFUSION SUSCEPTIBILITY TESTS [J].

JONES, RN ;

BARRY, AL ;

THORNSBERRY, C ;

GERLACH, EH ;

FUCHS, PC ;

GAVAN, TL ;

SOMMERS, HM .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :187-211

[9]

KAMMER RB, 1982, INFECT DIS S, V4, P712

[10] CLINICAL-EVALUATION OF MOXALACTAM [J].

LIVINGSTON, WK ;

ELLIOTT, AM ;

DISMUKES, WE ;

AVENT, CK ;

COBBS, CG .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (01) :88-97

← 1 2 3 →